UK Companies House feature
KENT SURREY SUSSEX AHSN LIMITED
Cash
£4M
+36% vs 2024
Net assets
£307K
+44.8% vs 2024
Employees
48
+2.1% vs 2024
Profit before tax
£123K
+168.7% vs 2024
Profile
- Company number
- 08877964
- Status
- Active
- Incorporation
- 2014-02-05
- Last accounts made up
- 2025-03-31
- Account category
- FULL
- Primary SIC
- 86900
- Hubs
- UK Healthcare
Net assets
6-year trend · vs UK Healthcare median
Accounts
6-year trend · latest 2025-03-31
| Metric | Trend | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|---|---|---|
| Turnover | £5,735,630 | £5,952,390 | — | — | — | — | |
| Operating profit | -£9,799 | £22,664 | — | — | — | — | |
| Profit before tax | £14,635 | £29,653 | £33,232 | -£66,571 | £45,773 | £122,987 | |
| Net profit | £9,633 | £27,451 | £21,328 | -£53,671 | £36,073 | £95,123 | |
| Cash | £4,540,397 | £4,710,363 | £3,902,598 | £3,635,029 | £2,596,413 | £3,532,330 | |
| Total assets less current liabilities | £680,941 | £548,392 | £556,480 | £405,149 | £441,222 | £536,645 | |
| Net assets | £180,941 | £208,392 | £229,720 | £176,049 | £212,122 | £307,245 | |
| Equity | £180,941 | £208,392 | £229,720 | £176,049 | £212,122 | £307,245 | |
| Average employees | 44 | — | 49 | 46 | 47 | 48 | |
| Wages | — | — | — | — | — | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102 §1A
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Sumer Audit
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a going concern basis. The directors have considered relevant information, including the annual budget, forecast future cash flows to 31 March 2027 and the impact of subsequent events in making their assessment. It has been announced that NHS England ('NHSE'), a body that commissions work to the Company, is to be abolished. Following this announcement the NHS put out their 'Fit for the Future: 10 Year Health Plan for England', which strongly indicated a continuation of the ongoing use of the Health Innovation networks following the abolishment. Our funding that has been commissioned through NHSE during the year ended 31 March 2025 approximates to 72% of the Company's total turnover. The Company is not aware at the time of signing these accounts of any possible cuts in funding from these bodies for the year ended 31 March 2027. Based on these assessments and having regard to the resources available to the entity, the directors have concluded that there is no material uncertainty in relation to the appropriateness of continuing to adopt the going concern basis in preparing the annual report and accounts.”
Significant events
- “In October 2023, the Company announced that a new five year licence to operate as a health innovation provider has been agreed until 30 September 2028, and that the Company would be operating under a new trading name of Health Innovation Kent Surrey Sussex (Health Innovation KSS).”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
9 active · 9 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ABDULHUSSEIN, Hatim Asgerali, Doctor | Director | 2024-04-01 | Aug 1991 | British |
| FERREUX, Mary Ann Lametu, Dr | Director | 2022-10-03 | Sep 1980 | British |
| HILL, Christopher Steven | Director | 2025-03-26 | Jun 1977 | British |
| JEFFRIES, Lisa | Director | 2024-03-27 | Feb 1977 | British |
| LANCASTER, Kate Victoria | Director | 2022-05-25 | Aug 1970 | British |
| LEE, Nigel Ronald | Director | 2020-01-20 | Sep 1961 | British |
| NICHOLSON, Zoe Clare | Director | 2022-05-25 | Jul 1967 | British |
| OLLIS, Jane Rebecca | Director | 2018-07-01 | Apr 1968 | British |
| PERERA, Chamintha Roshani | Director | 2021-01-11 | Oct 1978 | British |
Show 9 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BOERSMA, Guy Richard Douwe | Director | 2014-02-05 | 2022-01-31 |
| CARPENTER, Peter Edwin | Director | 2019-04-01 | 2023-09-12 |
| CLAYTON-SMITH, David Charles | Director | 2014-02-05 | 2023-06-30 |
| HOLDEN, Desmond Philip, Dr | Director | 2014-04-01 | 2023-12-29 |
| LEE-WRIGHT, Richard Anthony | Director | 2019-04-01 | 2021-11-18 |
| MCGREGOR, Patricia Jane | Director | 2014-05-21 | 2020-06-08 |
| VAN DER GAAG, Anna Danielle, Dr | Director | 2014-05-21 | 2022-03-31 |
| WEST, Martin Stephen, Dr | Director | 2014-05-21 | 2018-03-31 |
| WILES, Andrew Charles | Director | 2014-11-24 | 2015-07-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Central Surrey Health Limited | Corporate entity | Shares 25–50%, Voting 25–50% | 2016-04-06 | Active |
| Royal Surrey County Hospital Nhs Foundation Trust | Corporate entity | Shares 25–50%, Voting 25–50% | 2016-04-06 | Active |
Filing timeline
Last 20 of 58 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-05-02 | RESOLUTIONS | resolution | resolution |
| 2026-05-02 | MA | incorporation | memorandum articles |
| 2026-04-10 | CC04 | change-of-constitution | statement of companys objects |
| 2026-02-18 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2026-02-12 | CH01 | officers | change person director company with change date |
| 2025-12-12 | AA | accounts | accounts with accounts type full |
| 2025-12-05 | CH01 | officers | change person director company with change date |
| 2025-03-31 | AA | accounts | accounts with accounts type full |
| 2025-03-28 | AP01 | officers | appoint person director company with name date |
| 2025-02-18 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-06-27 | AP01 | officers | appoint person director company with name date |
| 2024-04-09 | AP01 | officers | appoint person director company with name date |
| 2024-02-09 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-01-10 | TM01 | officers | termination director company with name termination date |
| 2023-11-30 | AA | accounts | accounts with accounts type full |
| 2023-09-27 | TM01 | officers | termination director company with name termination date |
| 2023-07-13 | TM01 | officers | termination director company with name termination date |
| 2023-03-30 | AA | accounts | accounts with accounts type full |
| 2023-02-16 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-10-12 | AP01 | officers | appoint person director company with name date |
Credit score
Altman Z″ (private-firm) · reference 2025-03-31
0.87
DISTRESS
Altman Z″
- Working capital / Total assets 0.105 × 6.56 = +0.69
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets 0.016 × 6.72 = +0.11
- Book equity / Total liabilities 0.067 × 1.05 = +0.07
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory